Search

Your search keyword '"Camu, W"' showing total 445 results

Search Constraints

Start Over You searched for: Author "Camu, W" Remove constraint Author: "Camu, W"
445 results on '"Camu, W"'

Search Results

3. Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial

8. Association of Variants in the SPTLC1 Gene with Juvenile Amyotrophic Lateral Sclerosis

12. A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort

21. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis

22. Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain: Abstracts of Symposia and free communications

26. Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial

27. The HFE H63D (p.His63Asp) polymorphism is a modifier of ALS outcome in Italian and French patients with SOD1 mutations

29. NOMAD’ MUS : création d’une cohorte française de neuro-optico-myélite aiguë de Devic et des syndromes neurologiques apparentés

30. Neuromyélite optique de Devic et patients à haut risqué : enquête rétrospective nationale

32. Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis.

34. Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

36. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

37. Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

38. Phase III Dose-Comparison Study of Glatiramer Acetate for Multiple Sclerosis

39. SOD1 mutation can mask C9orf72 abnormal expansion

40. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

41. A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories

42. Living Lab MACVIA Handicap

43. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

44. Magnetic resonance imaging outcomes from a phase III trial of teriflunomide

45. Placebo effect characteristics observed in a single, international, longitudinal study in Huntington's disease

46. Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

47. Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis

48. [Longitudinal study of health related quality of life in multiple sclerosis: correlation with MRI parameters]

50. MACVIA-LR, Reference site of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) in Languedoc Roussillon

Catalog

Books, media, physical & digital resources